[Drug therapy of pheochromocytoma].
The Authors briefly review the clinical findings, the diagnostic biochemical procedures and the management of pheochromocytoma. The most recent pharmacological approaches with calcium-channel blockers or angiotensin-converting enzyme inhibitors are particularly discussed.
Coruzzi
P
P
Novarini
A
A
D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002216:Captopril / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007741:Labetalol / Q000627:therapeutic use; D009543:Nifedipine / Q000627:therapeutic use; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D010673:Pheochromocytoma / Q000188:drug therapy*; D011224:Prazosin / Q000627:therapeutic use
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002121:Calcium Channel Blockers; D010643:Phenoxybenzamine; D002216:Captopril; D009543:Nifedipine; D007741:Labetalol; D011224:Prazosin; D010646:Phentolamine
Terapia medica del feocromocitoma.